- Home
- NRGV vs EBS Comparison
NRGV vs EBS Comparison
Compare NRGV & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRGV
- EBS
- Stock Information
- Founded
- NRGV 2017
- EBS 1998
- Country
- NRGV United States
- EBS United States
- Employees
- NRGV N/A
- EBS N/A
- Industry
- NRGV Industrial Machinery/Components
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- NRGV Miscellaneous
- EBS Health Care
- Exchange
- NRGV Nasdaq
- EBS Nasdaq
- Market Cap
- NRGV 514.7M
- EBS 423.6M
- IPO Year
- NRGV N/A
- EBS 2006
- Fundamental
- Price
- NRGV $3.32
- EBS $9.91
- Analyst Decision
- NRGV Buy
- EBS Strong Buy
- Analyst Count
- NRGV 3
- EBS 2
- Target Price
- NRGV $1.58
- EBS $13.50
- AVG Volume (30 Days)
- NRGV 3.7M
- EBS 955.8K
- Earning Date
- NRGV 11-11-2025
- EBS 11-05-2025
- Dividend Yield
- NRGV N/A
- EBS N/A
- EPS Growth
- NRGV N/A
- EBS N/A
- EPS
- NRGV N/A
- EBS 2.53
- Revenue
- NRGV $51,716,000.00
- EBS $851,600,000.00
- Revenue This Year
- NRGV $314.58
- EBS N/A
- Revenue Next Year
- NRGV $39.00
- EBS $19.24
- P/E Ratio
- NRGV N/A
- EBS $3.93
- Revenue Growth
- NRGV N/A
- EBS N/A
- 52 Week Low
- NRGV $0.60
- EBS $4.02
- 52 Week High
- NRGV $3.79
- EBS $12.73
- Technical
- Relative Strength Index (RSI)
- NRGV 75.98
- EBS 74.08
- Support Level
- NRGV $2.69
- EBS $8.85
- Resistance Level
- NRGV $3.27
- EBS $9.34
- Average True Range (ATR)
- NRGV 0.38
- EBS 0.43
- MACD
- NRGV -0.00
- EBS 0.12
- Stochastic Oscillator
- NRGV 68.60
- EBS 99.29
About NRGV Energy Vault Holdings Inc.
Energy Vault Holdings Inc is a grid-scale energy storage company that is driving a faster transition to renewable power by solving the intermittence issues that are inherent to the prevalent sources of renewable energy, solar and wind. Geographical presence in United States, China and Other. Majority of its revenue comes from U.S.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.